← Back to Search

Text Message Reminders & Social Support for Chronic Diseases

N/A

Recruiting

Led By Sarah Schrauben, MD, MSCE

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of chronic kidney disease (any stage), hypertension, diabetes

Aged 18 years or over

Timeline

Screening 3 weeks

Treatment Varies

Follow Up collected with 12 weeks of study completion

Awards & highlights

Study Summary

This trial supports patients with chronic diseases by providing text message reminders & support to help track & manage blood pressure, leveraging social connections & gamification.

Who is the study for?

This trial is for adults over 18 with chronic kidney disease, hypertension, or diabetes who are patients at the University of Pennsylvania nephrology practice. They must have a blood pressure lower than 180/100 mmHg, own a smart device with internet and Bluetooth, understand English, and be able to give informed consent.Check my eligibility

What is being tested?

The SMART-HABITS for Health intervention supports self-management in patients with kidney disease, high blood pressure, and diabetes. It uses motivational text messages, goal setting prompts via texts leveraging social connections and gamification to encourage regular blood pressure monitoring.See study design

What are the potential side effects?

Since this trial involves behavioral interventions like text message reminders rather than medications or medical procedures, there are no direct physical side effects. However participants may experience stress or anxiety related to self-monitoring or changes in behavior.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have chronic kidney disease, high blood pressure, or diabetes.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ collected with 12 weeks of study completion

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~collected with 12 weeks of study completion

This trial's timeline: 3 weeks for screening, Varies for treatment, and collected with 12 weeks of study completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility: Acceptability of SMART-HABITS-4-Health

Feasibility: Adherence

Feasibility: Adoption

Secondary outcome measures

Chronic Kidney Diseases

Chronic disease

Disease Related Quality of Life

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Support PersonExperimental Treatment1 Intervention

A support person not in the study will receive the participant's weekly blood pressure performance details and will contact them at least on a weekly basis to encourage continued blood pressure monitoring. Prior to randomization, the participant will select a preference between a support person that is close to them (e.g., friend or family member) or a support person who is provided by the study, a Peer Mentor.

Group II: Social NormsExperimental Treatment1 Intervention

In this arm, participants will be texted reports of blood pressure performance statistics of the other participants in the study and also receive weekly feedback about how their blood pressure information compares to others in the study. Participants in this arm will have access to a leaderboard that displays this information.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,005 Previous Clinical Trials

42,882,227 Total Patients Enrolled

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,359 Previous Clinical Trials

4,314,532 Total Patients Enrolled

Sarah Schrauben, MD, MSCEPrincipal InvestigatorUniversity of Pennsylvania

1 Previous Clinical Trials

47 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the sample size of this clinical exploration?

"Affirmative. According to the clinicaltrials.gov database, this medical investigation began recruiting on August 21st 2023 and is still looking for candidates; 60 participants are necessary from a single research centre."

Answered by AI

Are there any current openings for this research experiment?

"Affirmative. Evidence on clinicaltrials.gov reveals this medical research is presently recruiting patients, having first been posted on August 21st 2023 and last updated on September 25th 2023. 60 participants are needed at a single site to continue the trial."

Answered by AI

What are the desired outcomes of this clinical investigation?

"The primary purpose of this 8-week study is to assess adherence of the participants. In addition, reach will be measured by comparing race frequencies between those enrolled and individuals with chronic kidney disease, diabetes, or hypertension in the US population. Furthermore, self-management capabilities will be evaluated through responses on a Partners in Health Scale for Chronic Condition Self-Management (11 questions). Finally, qualitative reports based off participant feedbacks detailing any adaptations made to schedule reminders/messaging content shall also be collected."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Supporting Self-Management of Healthy Behaviors in Diabetes, Kidney Disease, and Hypertension

2023. "Supporting Self-Management of Healthy Behaviors in Diabetes, Kidney Disease, and Hypertension". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05565716.